respiratory syncytial virus immune globulin (RSV-IGIV)
an immune serum.
indications It is used in children less than 2 years of age with bronchopulmonary dysplasia or in those born prematurely to prevent serious lower respiratory tract infection caused by respiratory syncytial virus.
contraindications Factors that prohibit its use are hypersensitivity to this drug or to other human immunoglobulin preparations and IgA deficiency.
adverse effects Life-threatening effects are respiratory distress, hypoxia, anaphylaxis, and angioneurotic edema. Other adverse effects are tachypnea, rales, wheezing, fever, hypertension, tachycardia, fluid overload, diarrhea, gastroenteritis, vomiting, rash, overdose effect, and inflammation at the injection site.
Abbreviation for respiratory syncytial virus immune globulin intravenous.